
CD274 molecule
Sign in to saveAlso known as B7 homolog 1, B7-H1 Antigen, PDCD1 ligand 1, B7-H1, programmed cell death 1 ligand 1, CD274, CD274 antigen, PD-L1
Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene.
Research
1,895 papers- Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity.Autophagy · 2025
- Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.Cancer cell · 2019
- A conserved dendritic-cell regulatory program limits antitumour immunity.Nature · 2020
- Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis.Cancer research · 2011
- Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics.Nature reviews. Clinical oncology · 2022
via PubMed
Clinical Trials
6 registered- PHASE1/PHASE2TERMINATEDA Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte Corporation · NCT05949632
- PHASE2ACTIVE_NOT_RECRUITINGStudy Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of TreatmentAmgen · NCT06502977
- PHASE2RECRUITINGNal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT06662006
- PHASE1COMPLETEDEvaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal CancersCentre Leon Berard · NCT02777710
- PHASE1RECRUITINGPomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVNational Cancer Institute (NCI) · NCT04902443
- PHASE2ACTIVE_NOT_RECRUITINGA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerLei Zheng · NCT05604560
~11 min read
Article
15 sectionsContents
- History
- Binding
- Signaling
- Regulation
- By interferons
- On macrophages and monocytes
- Role of microRNAs
- Epigenetic regulation
- Clinical significance
- Cancer
- ''Listeria monocytogenes''
- Autoimmunity
- See also
- References
- External links
Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene.
Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the adaptive arm of immune systems during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the adaptive immune system reacts to antigens that are associated with immune system activation by exogenous or endogenous danger signals. In turn, clonal expansion of antigen-specific CD8+ T cells and/or CD4+ helper cells is propagated. The binding of PD-L1 to the inhibitory checkpoint molecule PD-1 transmits an inhibitory signal based on interaction with phosphatases (SHP-1 or SHP-2) via Immunoreceptor Tyrosine-Based Switch Motif (ITSM). This reduces the proliferation of antigen-specific T-cells in lymph nodes, while simultaneously reducing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells) – further mediated by a lower regulation of the gene Bcl-2. PD-L1 is expressed on both hematopoietic and nonhematopoietic cells in tissues. However, the exact roles of PD-L1 on hematopoietic versus nonhematopoietic cells in modulating immune responses are unclear.